Significant long-term survival in unresectable hepatocellular carcinoma treated with radiofrequency ablation

被引：0
|
作者：
C. P. Raut
F. Izzo
P. Marra
L. M. Ellis
J. N. Vauthey
B. Danielle
P. Vallone
B. Fornage
S. A. Curley
机构：
[1] U.T.-M.D. Anderson Cancer Center,Department of Surgical Oncology
[2] G. Pascale National Cancer Institute,undefined
来源：
Annals of Surgical Oncology | 2004年 / 11卷
关键词：
Hospital Volume; Significant Proxy; 57TH Annual Cancer Symposium; Risk Adjust Odds; Hospital Volume Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：S73 / S73
相关论文
共 50 条
  • [41] Is radiofrequency ablation an effective long-term treatment for early-stage hepatocellular carcinoma?
    Jean-Francois Geschwind
    Eleni Liapi
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 302 - 303
  • [42] Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma
    Fang, Yong
    Chen, Wei
    Liang, Xiao
    Li, Da
    Lou, HaiZhou
    Chen, Renbiao
    Wang, Kaifeng
    Pan, HongMing
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 193 - 200
  • [43] Is radiofrequency ablation an effective long-term treatment for early-stage hepatocellular carcinoma?
    Geschwind, JF
    Liapi, E
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (07): : 302 - 303
  • [44] Long-Term Clinical Outcomes of Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤3 CM
    Cantamessa, Alessandro
    Gaia, Silvia
    Carucci, Patrizia
    Castiglione, Anna
    Rizzetto, Mario
    Brunello, Franco
    GASTROENTEROLOGY, 2012, 142 (05) : S983 - S983
  • [45] Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma
    Liu, Ming
    Li, Xiao-Ju
    Zhang, Xiao-Er
    Kuang, Ming
    Xie, Xiao-Yan
    Huang, Guang-Liang
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2023, 29 (02): : 342 - 349
  • [46] Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma
    Huang, Jingjun
    Huang, Wensou
    Guo, Yongjian
    Cai, Mingyue
    Zhou, Jingwen
    Lin, Liteng
    Zhu, Kangshun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Prognostic factors for survival after radiofrequency ablation for hepatocellular carcinoma (HCC): Long-term outcomes in 175 consecutive patients
    Kim, Sang-Gi
    Cho, Chang-Min
    Jeon, Seong-Woo
    Ha, Seung-Soo
    Do, Byung-Hun
    Jung, Si-Wook
    Tak, Wong-Young
    Kweon, Young-Oh
    Kim, Sung-Kook
    Choi, Yong-Hwan
    GASTROENTEROLOGY, 2006, 130 (04) : A773 - A774
  • [48] Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance
    Shoujin Cao
    Tianshi Lyu
    Zeyang Fan
    Haitao Guan
    Li Song
    Xiaoqiang Tong
    Jian Wang
    Yinghua Zou
    Cancer Imaging, 22
  • [49] Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance
    Cao, Shoujin
    Lyu, Tianshi
    Fan, Zeyang
    Guan, Haitao
    Song, Li
    Tong, Xiaoqiang
    Wang, Jian
    Zou, Yinghua
    CANCER IMAGING, 2022, 22 (01)
  • [50] Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system
    Francica, Giampiero
    Altiero, Michele
    Laccetti, Ettore
    Pezzullo, Filomena
    Tanga, Michela
    Avitabile, Giuseppe
    Elameer, Mathew
    Scaglione, Mariano
    BRITISH JOURNAL OF RADIOLOGY, 2018, 92 (1093):
12345